tezosentan

DRUG4 trials

Sponsors

Idorsia Pharmaceuticals Ltd.

Conditions

Acute Decompensation of Chronic Heart FailureAcute Heart FailureHeart DiseasesHypertension, PulmonaryNew Onset of Heart FailurePulmonary Arterial Hypertension

Phase 2

Tezosentan in Pulmonary Arterial Hypertension

TerminatedNCT01077297

Idorsia Pharmaceuticals Ltd.Pulmonary Arterial Hypertension

Start: 2010-08-31End: 2011-09-30Updated: 2018-07-09

Phase 3

Study of the Efficacy and Safety of Tezosentan in Patients With Pre-operative Pulmonary Hypertension, Due to Left Heart Disease, Undergoing Open Heart Surgery

TerminatedNCT00458276

Idorsia Pharmaceuticals Ltd.Heart Diseases, Hypertension, Pulmonary

Start: 2007-04-30End: 2008-03-31Updated: 2018-07-09

Tezosentan in the Treatment of Acute Heart Failure

CompletedNCT00524433

Idorsia Pharmaceuticals Ltd.Acute Decompensation of Chronic Heart Failure, Acute Heart Failure, New Onset of Heart Failure

Start: 2003-04-30End: 2005-01-31Updated: 2018-07-10

Tezosentan in Acute Heart Failure

CompletedNCT00525707

Idorsia Pharmaceuticals Ltd.Acute Decompensation of Chronic Heart Failure, Acute Heart Failure, New Onset of Heart Failure

Start: 2003-04-30End: 2005-01-31Updated: 2018-07-10

Related Papers

Predictors and Associations With Outcomes of Length of Hospital Stay in Patients With Acute Heart Failure: Results From VERITAS.

2015-12-2224 citations

Tezosentan and right ventricular failure in patients with pulmonary hypertension undergoing cardiac surgery: the TACTICS trial.

2013-03-2140 citations

Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials.

2007-11-01263 citations